Light-activated, photosensitizer-based therapies have been established as safe modalities
of tumour ablation for numerous cancer indications. Two main approaches are available …

Polymeric micelles are demonstrating high potential as nanomedicines capable of
controlling the distribution and function of loaded bioactive agents in the body, effectively …

The past few decades have witnessed an evolution of nanomedicine from biologically inert
entities to more smart systems, aimed at advancing in vivo functionality. However, we should …

A light-activated hypoxia-responsive conjugated polymer-based nanocarrier is developed
for efficiently producing singlet oxygen (1O2) and inducing hypoxia to promote release of its …

Indocyanine green (ICG) is a near-infrared dye that has been used in the clinic for retinal
angiography, and defining cardiovascular and liver function for over 50 years. Recently …

Hypoxia is a salient feature observed in most solid malignancies that holds a pivotal role in
angiogenesis, metastasis and resistance to conventional cancer therapeutic approaches …

Photodynamic therapy (PDT) is a clinical modality used to treat cancer and infectious
diseases. The main agent is the photosensitizer (PS), which is excited by light and converted …

Externally triggerable drug delivery systems provide a strategy for the delivery of therapeutic
agents preferentially to a target site, presenting the ability to enhance therapeutic efficacy …

Over the last three decades, a handful of photochemical mechanisms have been applied to
a large number of nanoscale assemblies that encapsulate a payload to afford spatio …

Biologically active compounds which are light‐responsive offer experimental possibilities
which are otherwise very difficult to achieve. Since light can be manipulated very precisely …